Johnson & Johnson

Kimberly-Clark to buy Tylenol maker Kenvue for over $40 billion

Kimberly-Clark would be scooping up the former Johnson & Johnson unit after months of struggle.

The company logo for Kenvue Inc. Johnson & Johnson's consumer-health business, is displayed on a screen during the company's IPO at the New York Stock Exchange (NYSE) in New York City, US, May 4, 2023.

Eyewear as jewelry and a fragrance campaign inspired by desert blossoms

Exotic recovery experience: New hair care brand comes to Israel

A health worker is seen preparing to administer the a third COVID-19 booster shot (illustrative).

COVID-19 booster shots are crucial, according to a Yale study


US eyes Tuesday deliveries of J&J vaccine, urges minorities to get shots

The officials gave no data on the disparities, but a health policy and research organization, found that POC are getting smaller shares of vaccinations as compared to their share of the population.

A vial and sryinge are seen in front of a displayed Johnson&Johnson logo in this illustration taken January 11, 2021.

US authorizes Johnson & Johnson's COVID-19 vaccine

The US Food and Drug Administration announced the emergency use authorization of the J&J vaccine for adults aged 18 & older following Friday's unanimous endorsement by the agency's panel of experts.

Vials with a sticker reading, "COVID-19 / Coronavirus vaccine/ Injection only" and a medical syringe are seen in front of a displayed Johnson & Johnson logo in this illustration taken October 31, 2020.

Johnson & Johnson expects COVID-19 vaccine data next week

Public health officials are increasingly counting on single-dose options like the one being tested by J&J to simplify and boost inoculations.

Coronavirus vaccine under development (illustrative)

AstraZeneca resumes US COVID-19 vaccine trial as J&J prepares to do same

AstraZeneca paused its US trial on Sept. 6 after a report of a serious neurological illness, believed to be transverse myelitis, in a participant in the company's UK trial.

A test tube labelled vaccine is seen in front of AstraZeneca logo in this illustration taken, September 9, 2020.

Nine US, European COVID-19 vaccine developers sign pledge to uphold safety

Nine CEOs sign historic pledge to continue to make the safety and well-being of vaccinated individuals the top priority in development of the first COVID-19 vaccines.

Bottles labeled "Vaccine" stand near medical syringe in front of "Coronavirus COVID-19" display (illustrative)

COVID-19 vaccine program to start production by late summer - US official

The US government has given grants ranging from several hundred million dollars to over $1 billion to Johnson & Johnson, Moderna Inc, AstraZeneca Plc and Novovax Inc.

Bottles labeled "Vaccine" stand near medical syringe in front of "Coronavirus COVID-19" display (illustrative)

COVID-19 supply disruption could be opportunity for Israeli start-ups

Israeli start-ups, focused on going global from day one, have already attracted many large companies to invest and establish a permanent presence in the country.

FILE PHOTO: Containers are loaded onto a ship, as the global outbreak of the coronavirus disease (COVID-19) continues, in the Port of Los Angeles, California, U.S., April 16, 2020

EU in advanced talks with Johnson & Johnson on COVID-19 vaccine deal

By buying vaccines under development, the EU risks acquiring shots that may eventually prove unsuccessful against COVID-19.

FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017

Johnson & Johnson to begin COVID-19 vaccine human trials in July

There are currently no US approved treatments or vaccines for the virus.

FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017